Compound #41 Targets Acute Myelogenous Leukemia by Inhibiting the Wnt/β-catenin Signaling Pathway
Yuki Hadate(Kyoto Pharmaceutical University), Eishi Ashihara(Kyoto Pharmaceutical University)
Cited by 2
Related Papers
6-Hydroxythiobinupharidine Inhibits Migration of LM8 Osteosarcoma Cells by Decreasing Expression of LIM Domain Kinase 1
|Anticancer Research|2019|13
DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line
|Anticancer Research|2019|9